Innate Pharma S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innate Pharma S.A. with three other
companies in this sector in France:
sales of 19.47 million Euro [US$22.22 million]
of which 100%
was Regenerative Medicine),
(29.60 million Euro [US$33.79 million]
of which 106%
was Therapeutics), and
(24.41 million Euro [US$27.87 million]
Innate Pharma S.A. reported sales of 32.63 million Euro (US$37.25 million)
December of 2017.
decrease of 41.9%
versus 2016, when the company's sales were 56.16 million Euro.